Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types
The objective of this post hoc exploratory analysis was to explore the impact of regorafenib on delaying HRQOL deterioration across three different tumor types.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 July 2021
|
| In: |
Cancer management and research
Year: 2021, Jahrgang: 13, Pages: 5523-5533 |
| ISSN: | 1179-1322 |
| DOI: | 10.2147/CMAR.S305939 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.2147/CMAR.S305939 Verlag: https://www.dovepress.com/effect-of-regorafenib-in-delaying-definitive-deterioration-in-health-r-peer-reviewed-fulltext-article-CMAR 
|
| Verfasserangaben: | Ralf-Dieter Hofheinz, Jordi Bruix, George D. Demetri, Axel Grothey, Marisca Marian, Jennifer Bartsch, Dawn Odom |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1831229374 | ||
| 003 | DE-627 | ||
| 005 | 20230707011003.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230117s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/CMAR.S305939 |2 doi | |
| 035 | |a (DE-627)1831229374 | ||
| 035 | |a (DE-599)KXP1831229374 | ||
| 035 | |a (OCoLC)1389538009 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 245 | 1 | 0 | |a Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types |c Ralf-Dieter Hofheinz, Jordi Bruix, George D. Demetri, Axel Grothey, Marisca Marian, Jennifer Bartsch, Dawn Odom |
| 264 | 1 | |c 12 July 2021 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.01.2023 | ||
| 520 | |a The objective of this post hoc exploratory analysis was to explore the impact of regorafenib on delaying HRQOL deterioration across three different tumor types. | ||
| 700 | 1 | |a Bruix, Jordi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Demetri, George D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grothey, Axel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marian, Marisca |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bartsch, Jennifer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Odom, Dawn |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer management and research |d Albany, Auckland : Dove Medical Press, 2009 |g 13(2021), Seite 5523-5533 |h Online-Ressource |w (DE-627)606030840 |w (DE-600)2508013-1 |w (DE-576)309422779 |x 1179-1322 |7 nnas |a Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g pages:5523-5533 |g extent:11 |a Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types |
| 856 | 4 | 0 | |u https://doi.org/10.2147/CMAR.S305939 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.dovepress.com/effect-of-regorafenib-in-delaying-definitive-deterioration-in-health-r-peer-reviewed-fulltext-article-CMAR |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20230117 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1831229374 |e 4248893932 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1831229374","type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"title":"Cancer management and research","title_sort":"Cancer management and research"}],"disp":"Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor typesCancer management and research","pubHistory":["1.2009 -"],"origin":[{"publisher":"Dove Medical Press","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Albany, Auckland"}],"id":{"zdb":["2508013-1"],"issn":["1179-1322"],"eki":["606030840"]},"part":{"extent":"11","year":"2021","pages":"5523-5533","volume":"13","text":"13(2021), Seite 5523-5533"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"606030840"}],"name":{"displayForm":["Ralf-Dieter Hofheinz, Jordi Bruix, George D. Demetri, Axel Grothey, Marisca Marian, Jennifer Bartsch, Dawn Odom"]},"physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"12 July 2021"}],"id":{"doi":["10.2147/CMAR.S305939"],"eki":["1831229374"]},"note":["Gesehen am 17.01.2023"],"person":[{"family":"Hofheinz","given":"Ralf-Dieter","role":"aut","display":"Hofheinz, Ralf-Dieter"},{"role":"aut","given":"Jordi","family":"Bruix","display":"Bruix, Jordi"},{"display":"Demetri, George D.","given":"George D.","role":"aut","family":"Demetri"},{"display":"Grothey, Axel","role":"aut","given":"Axel","family":"Grothey"},{"display":"Marian, Marisca","given":"Marisca","role":"aut","family":"Marian"},{"given":"Jennifer","role":"aut","family":"Bartsch","display":"Bartsch, Jennifer"},{"display":"Odom, Dawn","family":"Odom","given":"Dawn","role":"aut"}],"title":[{"title_sort":"Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types","title":"Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types"}]} | ||
| SRT | |a HOFHEINZRAEFFECTOFRE1220 | ||